NCT01566487View on ClinicalTrials.gov

Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Healthy
Interventions
DRUG

Quetiapine fumarate

Quetiapine fumarate tablets 300mg

Trial Locations (1)

380 061

Lambda Therapeutic Research Ltd, Ahmedabad

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY